STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2250 by analyst upside · 2026-08-13
HNGE
Hinge Health, Inc.
Healthcare · Market Cap $7B · P/E 10.8x
ANALYST PRICE TARGET
+21.8%
implied upside to consensus target
Current Price $86.32
Consensus Target $105.13
Bull Target $140.0
Bear Target $65.0
Analysts Covering 15
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
8
Hold
1
Sell
0
52-Week Low $30.08
52-Week High $93.13
YTD Return +89.5%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) 10.8x
Forward P/E 27.6x
EPS (TTM) $7.97
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $720M
Profit Margin 15.1%
52-WEEK RANGE
52-Week Low $30.08
52-Week High $93.13
Current Price $86.32
Bear Target $65.0
Bull Target $140.0
● Now $86.32 ● Target $105.13
TRADING DATA
Avg Volume 2.0M
YTD Return +89.5%
Analyst Count 15
Consensus Buy
Upside to Target +21.8%
Last Updated 2026-08-13

ANALYST SUMMARY

Hinge Health, Inc. (HNGE) is currently trading at $86.32 with a Wall Street consensus price target of $105.13, implying potential upside of 21.8% over the next 12 months. 15 analysts currently cover HNGE, with a consensus rating of Buy - 94% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $140.0, while the most cautious has a target of $65.0.

HNGE operates in the Healthcare sector with a market capitalisation of $7B. The stock is up 89.5% year-to-date and is currently trading near the upper end of its 52-week range of $30.08 – $93.13.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for HNGE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Baird - Reiterated
Neutral → Neutral 2026-06-17 Building track record
Raymond James - Reiterated
Outperform → Outperform 2026-06-15 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-06-15 Building track record
Keybanc - Reiterated
Overweight → Overweight 2026-06-12 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-06-11 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-06-11 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-06-11 Building track record
Needham - Reiterated
Buy → Buy 2026-06-11 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
56
out of 100
Coverage depth
21/30
Consensus clarity
13/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →